Long-term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight®) in previously treated patients with severe haemophilia A: interim results of the guardian™2 extension trial

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haemophilia : the official journal of the World Federation of Hemophilia 2015-09, Vol.21 (5), p.e436-e439
Hauptverfasser:	Ozelo, M., Misgav, M., Abdul Karim, F., Lentz, S. R., Martin-Salces, M., Matytsina, I., Saugstrup, T., Santagostino, E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Child Child, Preschool Confidence Intervals Factor VIII - adverse effects Factor VIII - therapeutic use Hemophilia A - complications Hemophilia A - drug therapy Hemorrhage - drug therapy Hemorrhage - etiology Hemorrhage - prevention & control Hemostatics - therapeutic use Humans Infant Middle Aged Time Factors Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!